Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis

Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation

(2019) Douglas S. Lewis et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Safe use of proton pump inhibitors in patients with cirrhosis

(2018) Rianne A. Weersink et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis

(2018) Elliot B. Tapper et al.   HEPATOLOGY

Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis

(2018) Tammo L. Tergast et al.   LIVER INTERNATIONAL

Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis

(2018) Jia Zhu et al.   United European Gastroenterology Journal

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

(2018) Lukas Sturm et al.   United European Gastroenterology Journal

Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics

(2018) Silvia Nardelli et al.   HEPATOLOGY

Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study

(2017) Chia-Fen Tsai et al.   GASTROENTEROLOGY

The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association

(2017) Daniel E. Freedberg et al.   GASTROENTEROLOGY

Proton pump inhibitors increase the risk for hepatic encephalopathy in patients with cirrhosis and ascites

(2017) D. Matei et al.   JOURNAL OF HEPATOLOGY

Association between proton pump inhibitors and hepatic encephalopathy

(2017) Jin Bian et al.   MEDICINE

Proton-pump inhibitors: understanding the complications and risks

(2017) Peter Malfertheiner et al.   Nature Reviews Gastroenterology & Hepatology

Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis

(2016) Kuang-Wei Huang et al.   European Journal of Internal Medicine

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

(2016) Gitte Dam et al.   HEPATOLOGY

Hepatic Encephalopathy

(2016) Eelco F.M. Wijdicks   NEW ENGLAND JOURNAL OF MEDICINE

Adverse Effects Associated With Proton Pump Inhibitors

(2016) Adam Jacob Schoenfeld et al.   JAMA Internal Medicine

Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis in Cirrhotic Patients with Ascites

(2016) Mélissa Ratelle et al.   Canadian Journal of Gastroenterology and Hepatology

Proton pump inhibitors affect the gut microbiome

(2015) Floris Imhann et al.   GUT

Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study

(2014) Y. W. Min et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Transjugular intrahepatic portosystemic shunts in liver transplant recipients

(2013) Alexander R. Bonnel et al.   LIVER TRANSPLANTATION

Transjugular Intrahepatic Portosystemic Shunt for Treatment of Cirrhosis-related Chylothorax and Chylous Ascites: Single-institution Retrospective Experience

(2012) Steven G. Kikolski et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis

(2012) Abhishek Deshpande et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The risks of PPI therapy

(2012) Paul Moayyedi et al.   Nature Reviews Gastroenterology & Hepatology

Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

(2010) Savio C Reddymasu et al.   BMC GASTROENTEROLOGY

Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding

(2010) Juan Carlos García-Pagán et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients With Cirrhosis

(2009) Renumathy Dhanasekaran et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study

(2009) Peter Jepsen et al.   HEPATOLOGY